Product Information

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.1484 per EA under NDC 71930002113. Its NADAC has been published 54 times since Nov 5, 2025.

FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1484per EA
DEA Schedule CII

Strength

325; 10 mg/1; mg/1

Manufacturer

Eywa Pharma Inc

NDC

71930002113

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210211

FDA Approved

10/30/2017

TE Code

AA

On Market Since

7/13/2018

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 54 times since Nov 5, 2025, and over the history we have for it it has declined 5.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1484 per EA
All-time high$0.1607 (Feb 11, 2026)
All-time low$0.1484 (Oct 21, 2026)
52-week high$0.1607
52-week low$0.1484
Median price$0.1534
Average price$0.1548
Largest weekly change-2.9% (Feb 18, 2026)
Weeks tracked54
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

-2.5%

3M

-3.2%

6M

-3.2%

1Y

-5.9%

3Y

N/A

5Y

N/A

All

-5.9%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by Eywa Pharma Inc, is $0.1484 per EA (NDC 71930002113), effective Nov 11, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 5.9%. It has been tracked across 54 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Since Nov 5, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1484 (Oct 21, 2026) to a high of $0.1607 (Feb 11, 2026), with a median of $0.1534 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1347 per EA — about 9% below HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 71930002113) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.